Zengjun Liu

4PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 24, 2026
Human Pancreatic Cancer Organoids.

|Oct 23, 2025
First-line Anlotinib plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft-Tissue Sarcoma: A Phase II Single-Arm Trial.

Jun-Kai Zhao, Zeng-Jun Liu, Rui Wang

|Aug 28, 2025
Sintilimab plus Anlotinib in Patients with Pretreated Locally Advanced or Metastatic Sarcoma: A Prospective, Single-Arm, Phase II Clinical Trial.

Heng Fu, Zengjun Liu, Mengyao Liu

|Apr 24, 2023
Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single-center experience of eight patients.

Zengjun Liu, Yang Xiao, Jing Xu

Pageof 1

Frequent Collaborators

3 joint publications

Dongyuan Zhu

2 joint publications

Heng Fu

2 joint publications

Mengyao Liu

2 joint publications

Jing Xu